-
Je něco špatně v tomto záznamu ?
DFNB49 is an important cause of non-syndromic deafness in Czech Roma patients but not in the general Czech population
D. Šafka Brožková, J. Laštůvková, H. Štěpánková, M. Krůtová, M. Trková, P. Myška, P. Seeman
Jazyk angličtina Země Dánsko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NS10552
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Wiley Online Library (archiv)
od 1997-01-01 do 2012-12-31
- MeSH
- etnicita genetika MeSH
- geny recesivní genetika MeSH
- hluchota genetika patologie MeSH
- homozygot MeSH
- jednonukleotidový polymorfismus genetika MeSH
- lidé MeSH
- MARVELD2 protein genetika MeSH
- mutační analýza DNA MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
Due to endogamy, the Roma have a higher risk for autosomal recessive (AR) disorders. We used homozygosity mapping on single-nucleotide polymorphism chips in one Czech Roma consanguineous family with non-syndromic hearing loss (NSHL). The second largest homozygous region in a deaf patient was mapped to the previously reported DFNB49 region. The MARVELD2 gene was recently reported as a causal gene for NSHL DFNB49. Sequencing of the MARVELD2 gene revealed a previously reported homozygous mutation c.1331+2 T>C (IVS4 + 2 T>C) in the deaf child. Subsequently, the same mutation was found in two more Roma families from an additional 19 unrelated Czech Roma patients with deafness tested for the MARVELD2 gene. To explore the importance of MARVELD2 mutations and DFNB49 for the general Czech and Central European population with early hearing loss we also tested 40 unrelated Czech patients with AR NSHL. No pathogenic mutation in the MARVELD2 gene was found in a group of 40 Czech non-Roma patients. Mutations in the MARVELD2 gene seem to be a significant cause of early NSHL in Czech Roma and this gene should be tested in this group of patients after GJB2.
Centre for Medical Genetics and Reproductive Medicine GENNET Prague Czech Republic
Department of Clinical Genetics Hospital České Budějovice České Budějovice Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13024486
- 003
- CZ-PrNML
- 005
- 20200129095634.0
- 007
- ta
- 008
- 130703s2012 dk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/j.1399-0004.2011.01817.x $2 doi
- 035 __
- $a (PubMed)22097895
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a dk
- 100 1_
- $a Šafka Brožková, D. $u DNA Laboratory, Department of Child Neurology, Charles University 2nd Medical School and University Hospital Motol, Prague, Czech Republic. dana.brozkova@seznam.cz
- 245 10
- $a DFNB49 is an important cause of non-syndromic deafness in Czech Roma patients but not in the general Czech population / $c D. Šafka Brožková, J. Laštůvková, H. Štěpánková, M. Krůtová, M. Trková, P. Myška, P. Seeman
- 520 9_
- $a Due to endogamy, the Roma have a higher risk for autosomal recessive (AR) disorders. We used homozygosity mapping on single-nucleotide polymorphism chips in one Czech Roma consanguineous family with non-syndromic hearing loss (NSHL). The second largest homozygous region in a deaf patient was mapped to the previously reported DFNB49 region. The MARVELD2 gene was recently reported as a causal gene for NSHL DFNB49. Sequencing of the MARVELD2 gene revealed a previously reported homozygous mutation c.1331+2 T>C (IVS4 + 2 T>C) in the deaf child. Subsequently, the same mutation was found in two more Roma families from an additional 19 unrelated Czech Roma patients with deafness tested for the MARVELD2 gene. To explore the importance of MARVELD2 mutations and DFNB49 for the general Czech and Central European population with early hearing loss we also tested 40 unrelated Czech patients with AR NSHL. No pathogenic mutation in the MARVELD2 gene was found in a group of 40 Czech non-Roma patients. Mutations in the MARVELD2 gene seem to be a significant cause of early NSHL in Czech Roma and this gene should be tested in this group of patients after GJB2.
- 650 _2
- $a mutační analýza DNA $7 D004252
- 650 _2
- $a hluchota $x genetika $x patologie $7 D003638
- 650 _2
- $a etnicita $x genetika $7 D005006
- 650 _2
- $a geny recesivní $x genetika $7 D005808
- 650 _2
- $a homozygot $7 D006720
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a MARVELD2 protein $x genetika $7 D062794
- 650 _2
- $a jednonukleotidový polymorfismus $x genetika $7 D020641
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Laštůvková, J. $u Department of Medical Genetics, Masaryk Hospital, Regional Health Corporation, Ústí nad Labem, Czech Republic
- 700 1_
- $a Štěpánková, Helena $7 xx0244385 $u Department of Clinical Genetics, Hospital České Budějovice, České Budějovice, Czech Republic
- 700 1_
- $a Krůtová, M. $u DNA Laboratory, Department of Child Neurology, Charles University 2nd Medical School and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Trková, M. $u Centre for Medical Genetics and Reproductive Medicine GENNET, Prague, Czech Republic
- 700 1_
- $a Myška, P. $u Department of Otorhinolaryngology, Charles University 2nd Medical School and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Seeman, P. $u DNA Laboratory, Department of Child Neurology, Charles University 2nd Medical School and University Hospital Motol, Prague, Czech Republic
- 773 0_
- $w MED00001127 $t Clinical genetics $x 1399-0004 $g Roč. 82, č. 6 (2012), s. 579-582
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22097895 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130703 $b ABA008
- 991 __
- $a 20200129100016 $b ABA008
- 999 __
- $a ok $b bmc $g 988166 $s 822866
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 82 $c 6 $d 579-582 $i 1399-0004 $m Clinical genetics $n Clin Genet $x MED00001127
- GRA __
- $a NS10552 $p MZ0
- LZP __
- $a Pubmed-20130703